pharmaphorum

OCTOBER 27, 2020

Merimepodib is the subsidiary’s primary asset, and the biotech now says it is to offers to acquire or license the drug. The post BioSig abandons COVID-19 drug trial on safety concerns appeared first on. BioSig has previously said it was considering a spin-out of ViralClear. Image credit: Rocky Mountain Labs/NIH.

Drug Trials 98

Drug Trials Trials Drugs Contract Manufacturing 98

XTalks

APRIL 26, 2021

It is the world’s first and only licensed malaria vaccine and also the first licensed for use against a human parasitic disease of any kind. Children have been the focus of malaria vaccine and drug trials because over 90 percent of deaths attributable to malaria are in African children under the age of five.

Vaccination 105

Vaccination Vaccine Immune Response Trials 105

Drug Discovery World

FEBRUARY 20, 2023

AstraZeneca’s Evusheld became the first antibody combination for pre-exposure prophylaxis (PrEP) against Covid-19 licensed in the UK. The post What are the top disease areas for clinical drug trials? appeared first on Drug Discovery World (DDW).

Drug Trials 52

Drug Trials Trials Clinical Trials Clinical Trials 52

pharmaphorum

JANUARY 25, 2021

Immutep said a collaboration with GSK remains in place and GSK2831781 continues to be under exclusive license with GSK. The company’s hopes for the drug lie in other autoimmune diseases – it has already been tested in a phase 1 psoriasis trial showing preliminary signs of efficacy.

Drug Trials 85

Drug Trials Trials Drugs Licensing 85

Drug Discovery World

JULY 20, 2023

What are benefits of drug repurposing and why do clinical drug trials so often fail? Diana Spencer summarises the key messages from the ‘Drug Repurposing: Challenges and Opportunities’ Symposium held at the 19th World Congress of Basic & Clinical Pharmacology (WCP) 2023.

Drugs 40

Drugs Clinical Trials Clinical Trials Trials 40

Drug Discovery World

MARCH 7, 2023

She has over 15 years’ experience in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing. She founded Neuroute in 2019, with the aim of empowering patients from diverse backgrounds to participate in drug trials.

Life Science 98

Life Science DNA Clinical Development Development 98

Delveinsight

AUGUST 12, 2021

LQTT has a portfolio of in-licensed compounds from Sanofi that prohibit serum/glucocorticoid-regulated kinase 1, or SGK1. AbbVie reported the success of two phase 3 trials of its drug trial in October and filed for FDA approval in February.

Trials 97

Trials Clinical Trials Clinical Trials Regulation 97